Sylogist Ltd. (TSX:SYZ)
Canada · Delayed Price · Currency is CAD | Market Cap | 64.53M -49.0% |
| Revenue (ttm) | 59.65M -6.6% |
| Net Income | -8.45M |
| EPS | -0.36 |
| Shares Out | 23.29M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.02 (0.72%) |
| Ex-Dividend Date | Feb 27, 2026 |
| Volume | 2,157 |
| Open | 2.790 |
| Previous Close | 2.810 |
| Day's Range | 2.730 - 2.800 |
| 52-Week Range | 2.310 - 6.000 |
| Beta | 0.63 |
| Analysts | Buy |
| Price Target | 4.44 (+60.22%) |
| Earnings Date | Nov 11, 2026 |
About Sylogist
Sylogist Ltd., a software company, provides mission-critical software-as-a-service solutions to public sector customers in Canada, the United States, the United Kingdom, and internationally. The company offers SylogistMission platform, including CRM system, donor management; online fundraising; and volunteer, event, program, and campaign management, as well as ERP system, such as fund accounting; core financial tools; human resource and personal management; and automation, analytical, and reporting. It also provides SylogistEd platform comprisi... [Read more]
Financial Performance
In 2025, Sylogist's revenue was 62.24 million, a decrease of -5.12% compared to the previous year's 65.60 million. Losses were -4.66 million, 540.4% more than in 2024.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for SYZ stock is "Buy." The 12-month stock price target is $4.44, which is an increase of 60.22% from the latest price.
News
Sylogist Announces Release Date for Its Third Quarter 2026 Results
Calgary, Alberta--(Newsfile Corp. - November 2, 2026) - Sylogist Ltd. (TSX: SYZ) ("Sylogist" or the "Company"), a leading public sector SaaS company, announced today that it will release its third qua...
Sylogist downgraded to Speculative Buy from Outperform at ATB Cormark
ATB Cormark downgraded Sylogist (SYZLF) to Speculative Buy from Outperform with a C$4.75 price target
Sylogist price target lowered to C$3.25 from C$3.75 at Stifel
Stifel lowered the firm’s price target on Sylogist (SYZLF) to C$3.25 from C$3.75 and keeps a Hold rating on the shares.
Sylogist Earnings Call Transcript: Q2 2026
SaaS revenue and ARR grew year-over-year, but total revenue declined due to weaker project services and hardware sales. Adjusted EBITDA margin improved sequentially, and recurring revenue mix increased. Optimization initiatives and restructuring are expected to support future growth and profitability.
Sylogist MD&A: Q2 2026
Sylogist filed a regulatory document on August 12, 2026 disclosing important business information.
Sylogist Earnings release: Q2 2026
Sylogist released its Q2 2026 earnings on August 12, 2026, summarizing the period's financial results.
Sylogist Report: Q2 2026
Sylogist published a report on August 12, 2026 containing material business information for investors and shareholders.
Sylogist price target lowered to C$3.75 from C$4.50 at Stifel
Stifel analyst Suthan Sukumar lowered the firm’s price target on Sylogist (SYZLF) to C$3.75 from C$4.50 and keeps a Hold rating on the shares.
Sylogist Earnings Call Transcript: Q1 2026
Q1 2026 saw SaaS and recurring revenue growth, but total revenue declined due to lower project services. SaaS transformation is progressing, with strong pipelines in Gov and VSS segments and stabilization expected in Mission. Dividend suspended in favor of share buybacks.
Sylogist Earnings release: Q1 2026
Sylogist released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.
Sylogist Report: Q1 2026
Sylogist published a report on May 12, 2026 containing material business information for investors and shareholders.
Sylogist MD&A: Q1 2026
Sylogist filed a regulatory document on May 12, 2026 disclosing important business information.
Sylogist Shareholders Reminded to Vote FOR Director Nominees Using Only the BLUE Proxy
Approximately 45% of all Sylogist shares voted in favour of Sylogist Director Nominees A leading independent proxy advisory firm has provided full endorsement to Sylogist-endorsed nominees, while reje...
Leading Independent Proxy Advisory Firm Gives Full Endorsement to Sylogist-Endorsed Nominees, Rejects OneMove's Case
ISS recommends shareholders vote FOR Sylogist's six director nominees and Board-supported OneMove nominee Mary Filippelli using only the BLUE proxy ISS recommends shareholders WITHHOLD from OneMove's ...
Sylogist Announces Release Date for Its First Quarter 2026 Results
Calgary, Alberta--(Newsfile Corp. - April 30, 2026) - Sylogist Ltd. (TSX: SYZ) ("Sylogist" or the "Company"), a leading public sector SaaS company, announced today that it will release its first quart...
Sylogist Files Management Information Circular in Connection with Annual and Special Meeting of Shareholders
CALGARY, Alberta, April 17, 2026 (GLOBE NEWSWIRE) -- Sylogist Ltd. (TSX: SYZ) ("Sylogist" or the "Company"), a leading public sector SaaS company, today announced that it has filed its management info...
Sylogist receives advance notice of nominations from OneMove Capital
Sylogist (SYZLF) confirmed receipt of advance notice of nomination of directors from OneMove Capital. The Company is reviewing the Notice with its advisors. The company said, “Consistent with OneMove’...
Sylogist Receives Advance Notice of Nomination of Directors from OneMove Capital
CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) -- Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the “Company”), a leading public sector SaaS company, today confirmed receipt of advance notice of nominati...
Sylogist price target lowered to C$4.50 from C$4.75 at Stifel
Stifel lowered the firm’s price target on Sylogist (SYZLF) to C$4.50 from C$4.75 and keeps a Hold rating on the shares.
Sylogist Earnings Call Transcript: Q4 2025
Q4 and FY2025 results reflect a successful SaaS transformation, with recurring revenue reaching 81% of Q4 revenue and SaaS ARR up 9% year-over-year. Margins compressed due to the shift to partner-led delivery, but management expects improved growth and profitability as the transition nears completion.
Sylogist Earnings release: Q4 2025
Sylogist released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.
Sylogist Report: Q4 2025
Sylogist published a report on March 19, 2026 containing material business information for investors and shareholders.
Sylogist MD&A: Q4 2025
Sylogist filed a regulatory document on March 19, 2026 disclosing important business information.
Sylogist Annual report: Q4 2025
Sylogist has published its Q4 2025 annual report on March 19, 2026.
Sylogist reports Q4 revenue C$14.4M, down 6.2% year-over-year
“Sylogist (SYZLF) has a committed and talented team, a portfolio of mission-critical software solutions that are highly effective at addressing the needs of our customers, and we’ve built a strong…